NATCO gets US FDA nod for Everolimus tablets
They are indicated in the treatment of breast cancer and a few other types of cancers
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Natco Pharma
NATCO launches Brivaracetam tablets in India
Brivaracetam is indicated towards treatment of epilepsy.
Natco Pharma gets registration approval from CIB&RC for Chlorantraniliprole
Natco Pharma has received registration approval from Central Insecticide Board and Registration Committee for Chlorantraniliprole,…
NATCO launches Rivaroxaban¸ anticoagulant medication in India
Rivaroxaban is currently sold by Bayer under brand name of Xarelto, in the Indian market
NATCO gets US FDA approval for Pomalidomide capsules
It is indicated for the treatment of multiple myeloma
Canada subsidiary of Natco Pharma in settlement agreement with Celgene for onco drug
The terms of the agreement are confidential as per the agreement
NATCO supports Columbia University’s clinical trial of chloroquine phosphate
Researchers at Columbia University are conducting this critical study to assess CQ
as prophylaxis against COVID-19 in healthcare…
Natco Pharma gets USFDA approval for Visakhapatnam facility
The company did not disclose the product approved by the USFDA to be produced from the facility
Dapnat launch to boost Natco’s presence in India’s diabetes market but concerted efforts required,…
Natco is a new player within the cardiovascular and diabetes therapeutic space, launching its Cardiology and Diabetic (CnD)…
Natco Pharma gets EIR from USFDA for Telangana facility
USFDA had conducted pre-approval inspection at Natco’s facility in Kothur village from March 2-6, 2020